Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease

Movement Disorders

Volumn 15, Issue 1, 2000, Pages 167-169

  Factor, Stewart A ^a,b   Brown, Diane L ^b   Molho, Eric S ^b  

^a Department of Neurology   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CARBIDOPA PLUS LEVODOPA; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOLE;

AGED; ARTICLE; CASE REPORT; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INTRACTABLE PAIN; ON OFF PHENOMENON; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; APOMORPHINE; DOPAMINE AGONISTS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; PAIN, INTRACTABLE; PARKINSON DISEASE;

EID: 0033979955     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200001)15:1<167::AID-MDS1029>3.0.CO;2-8     Document Type: Article

References (13)

1. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord 1986;1:45-49.
2. Hillen ME, Sage JI. Non-motor fluctuations in patients with Parkinson's disease. Neurology 1996;47:1180-1183.
3. Riley DE, Lang AE. The spectrum of levodopa-related fluctuations in Parkinson's disease. Neurology 1993;43:1459-1464.
4. Quinn NP, Koller WC, Lang AE, Marsden CD. Painful Parkinson's disease. Lancer 1986;1:1366-1369.
5. Frankel JP, Lees AJ, Kempster PA, et al. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:96-101.
6. Hughes AJ, Bishop S, Kleedorfer B, et al. Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to 5 years. Mov Disord 1993;8:165-170.
7. Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P, Garcia-Urra D. 'Panic attacks' in Parkinson's disease: a long term complication of levodopa therapy. Acta Neurol Scand 1993;87:14-18.
8. Richard IH, Schiffer RB, Kurlan R. Anxiety in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1996;8:383-392.
9. Quinn N, Marsden CD. Lithium for painful dystonia in Parkinson's disease. Lancet 1986;1:1377.
10. Juncos JL. Clozapine treatment of parkinsonian pain syndromes. Mov Disord 1996;11:603-604.
11. Factor SA. Acetazolamide therapy of menstrual-related fluctuations in Parkinson's disease. Mov Disord 1993;8:240-241.
12. Lieberman AN, Ranhosky A, Korts D. Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study. Neurology 1997; 49:162-168.
13. Adler CH, Singer C, O'Brien C, et al. Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson's disease treated with levodopa-carbidopa. Arch Neurol 1998; 55:1089-1095.